February 21, 2018 / 12:08 PM / 7 months ago

BRIEF-The Medicines Q4 GAAP Loss Per Share $2.19 From Continuing Operations

Feb 21 (Reuters) - Medicines Co:

* THE MEDICINES COMPANY REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 BUSINESS AND FINANCIAL RESULTS

* Q4 REVENUE $8.6 MILLION

* Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.61 FROM CONTINUING OPERATIONS

* WORLDWIDE NET REVENUE WAS $8.6 MILLION IN Q4 OF 2017 VERSUS $17.4 MILLION IN Q4 OF 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below